Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

The move would trigger an overhaul of scores of products on U.S. grocery store shelves. The plan was announced Tuesday ...

Details were expected to be announced Tuesday afternoon by Health Secretary Robert F. Kennedy Jr. and Food and Drug ...

What changes has RFK Jr. enacted so far and what does the future of American health under his leadership look like?

Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...

People are not born allergic to things, but they can be born with a genetic tendency to become allergic to things to which ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

Beleaguered Belgian biotech Galapagos said yesterday that its CEO, Paul Stoffels, plans to retire upon the appointment of his ...